Givinostat also has been tested in adults with Becker muscular dystrophy. Top-line results from a Phase 2 trial (NCT03238235) showed that treatment failed to reduce muscle scarring, a main trial goal, but its use stopped further muscle shrinkage and fat infiltration, suggesting it may slow or prevent disease progression.
I wasnt correct in what I said about the adult trial.
- Forums
- ASX - By Stock
- For General Information
Givinostat also has been tested in adults with Becker muscular...
-
- There are more pages in this discussion • 864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
-0.002(2.00%) |
Mkt cap ! $66.26M |
Open | High | Low | Value | Volume |
7.5¢ | 7.5¢ | 7.1¢ | $23.47K | 321.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 29672 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 29672 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
3 | 33055 | 0.068 |
1 | 9310 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 50000 | 1 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
0.081 | 25000 | 1 |
Last trade - 12.34pm 30/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online